메뉴 건너뛰기




Volumn 49, Issue 6, 2004, Pages 1847-1850

Solubility of valdecoxib in the presence of ethanol and sodium lauryl sulfate at (298.15, 303.15, and 308.15) K

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; BINARY MIXTURES; CONCENTRATION (PROCESS); DATABASE SYSTEMS; ETHANOL; GIBBS FREE ENERGY; GRAPHIC METHODS; HYDROCARBONS; LINEAR EQUATIONS; PERMITTIVITY; SURFACE ACTIVE AGENTS; VOLUME FRACTION;

EID: 9744273197     PISSN: 00219568     EISSN: None     Source Type: Journal    
DOI: 10.1021/je0496948     Document Type: Article
Times cited : (24)

References (16)
  • 1
    • 0034601240 scopus 로고    scopus 로고
    • Improving drug solubility for oral delivery using solid dispersions
    • Leuner, C.; Dressman, J. Improving Drug Solubility for Oral Delivery Using Solid Dispersions. Eur. J. Pharm. Biopharm. 2000, 50, 47-60.
    • (2000) Eur. J. Pharm. Biopharm. , vol.50 , pp. 47-60
    • Leuner, C.1    Dressman, J.2
  • 2
    • 0019166075 scopus 로고
    • Solubility and partitioning: Solubility of nonelectrolytes in water
    • Yalkwosky, S. H.; Valvani, S. C. Solubility and Partitioning: Solubility of Nonelectrolytes in Water. J. Pharm. Sci. 1980, 69, 912-922.
    • (1980) J. Pharm. Sci. , vol.69 , pp. 912-922
    • Yalkwosky, S.H.1    Valvani, S.C.2
  • 3
    • 0038768850 scopus 로고    scopus 로고
    • Influence of physiochemical properties on dissolution of drugs in the gastrointestinal tract (review)
    • Hoerter, D.; Dressman, J. B. Influence of Physiochemical Properties on Dissolution of Drugs in the Gastrointestinal Tract (review). Adv. Drug. Delivery Rev. 1997, 25, 3-14.
    • (1997) Adv. Drug. Delivery Rev. , vol.25 , pp. 3-14
    • Hoerter, D.1    Dressman, J.B.2
  • 4
    • 0042307682 scopus 로고    scopus 로고
    • Solubility of rofecoxib in the presence of methanol, ethanol, and sodium lauryl sulfate at (298.15, 303.15, and 308.15) K
    • Desai, K. G. H.; Kulkarni, A. R.; Aminabhavi, T. M. Solubility of Rofecoxib in the Presence of Methanol, Ethanol, and Sodium Lauryl Sulfate at (298.15, 303.15, and 308.15) K. J. Chem. Eng. Data. 2003, 48, 942-945.
    • (2003) J. Chem. Eng. Data. , vol.48 , pp. 942-945
    • Desai, K.G.H.1    Kulkarni, A.R.2    Aminabhavi, T.M.3
  • 5
    • 1242337285 scopus 로고    scopus 로고
    • Solubilizing excipients in oral and injectable formulations
    • Strickley, R. G. Solubilizing Excipients in Oral and Injectable Formulations. Pharm. Res. 2004, 21, 201-230.
    • (2004) Pharm. Res. , vol.21 , pp. 201-230
    • Strickley, R.G.1
  • 6
    • 0142062969 scopus 로고    scopus 로고
    • Solubility of guaifenesin in the presence of common pharmaceutical additives
    • Mani, N.; Jun, H. W.; Beach, J. W.; Nerukar, J. Solubility of Guaifenesin in the Presence of Common Pharmaceutical Additives. Pharm. Dev. Technol. 2003, 8, 385-396.
    • (2003) Pharm. Dev. Technol. , vol.8 , pp. 385-396
    • Mani, N.1    Jun, H.W.2    Beach, J.W.3    Nerukar, J.4
  • 7
    • 0031590684 scopus 로고    scopus 로고
    • Management of osteoarthritis in the primary-care setting: An evidence-based approach to treatment
    • Lane, N. E.; Thompson, J. M. Management of Osteoarthritis in the Primary-care Setting: An Evidence-based Approach to Treatment. Am. J. Med. 1997, 103, 25-35.
    • (1997) Am. J. Med. , vol.103 , pp. 25-35
    • Lane, N.E.1    Thompson, J.M.2
  • 8
    • 0030829359 scopus 로고    scopus 로고
    • The discovery and function of Cox2
    • Needleman, P.; Isakson, P. C. The Discovery and Function of Cox2. J. Rheumatol. 1997, 24, 2-7.
    • (1997) J. Rheumatol. , vol.24 , pp. 2-7
    • Needleman, P.1    Isakson, P.C.2
  • 9
    • 1542339420 scopus 로고    scopus 로고
    • Oral valdecoxib and injected paracoxib for acute postoperative pain: A quantitative systematic review
    • Barden, J.; Edwards, J. E.; McQuay, H. J.; Moore, R. A. Oral Valdecoxib and Injected Paracoxib for Acute Postoperative Pain: A Quantitative Systematic Review. BMC Anesthesiol. 2003, 3, 1-8.
    • (2003) BMC Anesthesiol. , vol.3 , pp. 1-8
    • Barden, J.1    Edwards, J.E.2    McQuay, H.J.3    Moore, R.A.4
  • 11
    • 0035246513 scopus 로고    scopus 로고
    • Cyclooxygenase inhibitors-current status and future prospects
    • Dannhardt, G.; Kiefer, W. Cyclooxygenase Inhibitors-Current Status and Future Prospects. Eur. J. Med. Chem. 2001, 36, 109-126.
    • (2001) Eur. J. Med. Chem. , vol.36 , pp. 109-126
    • Dannhardt, G.1    Kiefer, W.2
  • 12
    • 0021960184 scopus 로고
    • Solubilization of cosolvents 1: Organic solutes in propylene glycol-water mixtures
    • Yalkowsky, S. H.; Rubino, J. T. Solubilization of Cosolvents 1: Organic Solutes in Propylene Glycol-Water Mixtures. J. Pharm. Sci. 1985, 74, 416-421.
    • (1985) J. Pharm. Sci. , vol.74 , pp. 416-421
    • Yalkowsky, S.H.1    Rubino, J.T.2
  • 13
    • 0036805534 scopus 로고    scopus 로고
    • Solubilization by cosolvents: Establishing useful constants for the log-linear model
    • Millard, J. W.; Alvarez-Nunez, F. A.; Yalkowsky, S. H. Solubilization by Cosolvents: Establishing Useful Constants for the Log-linear Model. Int. J. Pharm. 2002, 245, 153-166.
    • (2002) Int. J. Pharm. , vol.245 , pp. 153-166
    • Millard, J.W.1    Alvarez-Nunez, F.A.2    Yalkowsky, S.H.3
  • 15
    • 0034028222 scopus 로고    scopus 로고
    • Aqueous solubility of diclofenac diethylamine in the presence of pharmaceutical additives: A comparative study with diclofenac sodium
    • Khalil, E.; Najjar, S.; Sallam, A. Aqueous Solubility of Diclofenac Diethylamine in the Presence of Pharmaceutical Additives: A Comparative Study with Diclofenac Sodium. Drug Dev. Ind. Pharm. 2000, 26, 375-381.
    • (2000) Drug Dev. Ind. Pharm. , vol.26 , pp. 375-381
    • Khalil, E.1    Najjar, S.2    Sallam, A.3
  • 16
    • 0035660775 scopus 로고    scopus 로고
    • Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity
    • Tang, L.; Khan, S. U.; Muhammad, N. A. Evaluation and Selection of Bio-Relevant Dissolution Media for a Poorly water-Soluble New Chemical Entity. Pharm. Dev. Technol. 2001, 6, 531-540.
    • (2001) Pharm. Dev. Technol. , vol.6 , pp. 531-540
    • Tang, L.1    Khan, S.U.2    Muhammad, N.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.